Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Roche plans to launch Phase 3 studies of its leading obesity […]
Read MoreIndian court allows sales of generic for costly Roche SMA drug Evrysdi
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought to prevent a generic drugmaker from selling a lower-cost version […]
Read MoreAstraZeneca, Genentech, Roche, Takeda Day 3 news
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech […]
Read More